Susan K Eleeson Inc | |
47143 299th St Beresford SD 57004 | |
(605) 351-5826 | |
Not Available |
Full Name | Susan K Eleeson Inc |
---|---|
Speciality | Psychologist |
Location | 47143 299th St, Beresford, South Dakota |
Authorized Official Name and Position | Susan Kristine Eleeson (CEO/LICENSED PSYCHOLOGIST) |
Authorized Official Contact | 6053515826 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Susan K Eleeson Inc 47143 299th St. Beresford SD 57004 Ph: (605) 351-5826 | Susan K Eleeson Inc 47143 299th St Beresford SD 57004 Ph: (605) 351-5826 |
NPI Number | 1275903312 |
---|---|
Provider Enumeration Date | 10/01/2015 |
Last Update Date | 02/01/2024 |
Certification Date | 01/22/2024 |
Identifier | Type | State | Issuer |
---|---|---|---|
1275903312 | NPI | - | NPPES |
1568417657 | Medicaid | SD | |
S107742 | Other | SD | PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 399 (South Dakota) | Primary |
News Archive
The Internet, smart phones and teens' endless search for self-acceptance in their technology connected yet isolated world is driving a revival of substance abuse of salvia, an herb from flower seeds that induces psychedelic effects but is not detectable with usual drug tests, and synthetic cannabis, a psychoactive herbal and chemical concoction, also undetectable, popularly known around high schools as "spice".
Recurring patterns in patient accounts suggest the existence of an inverse relationship between personal history of infectious fever and cancer risk, and these patterns are documented throughout decades of medical literature.
Researchers who developed a safe and effective procedure to remove thick clogs in children's airways are now reporting similar success in adult patients. In this rare condition, called plastic bronchitis, patients develop thick, caulk-like casts that form in the branching paths of their airways.
The Food and Drug Administration may eliminate a program that allows medical devices to be approved quickly because of concerns the program is overused, The Wall Street Journal reports. An internal FDA memo proposes the elimination or tightening of the "fast track" as officials question the use of private, third-party companies "hired by device makers to pre-review products.
Better medical responses to the accidental or intentional release of inhaled toxic chemicals are being developed, but the field faces considerable challenges, according to a new report by an international panel of experts.
› Verified 5 days ago